Group One Trading’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.7M Buy
171,300
+53,900
+46% +$4.31M 0.02% 801
2025
Q4
$11.2M Sell
117,400
-52,900
-31% -$5.19M 0.02% 889
2025
Q3
$16.6M Buy
170,300
+50,700
+42% +$5.25M 0.03% 584
2025
Q2
$12.8M Buy
119,600
+35,700
+43% +$3.61M 0.03% 659
2025
Q1
$8.46M Buy
83,900
+46,500
+124% +$4.68M 0.02% 731
2024
Q4
$3.34M Sell
37,400
-50,500
-57% -$4.45M 0.01% 1467
2024
Q3
$7.37M Buy
87,900
+63,700
+263% +$5.02M 0.02% 765
2024
Q2
$1.86M Buy
24,200
+15,600
+181% +$1.14M 0.01% 1508
2024
Q1
$589K Sell
8,600
-203,700
-96% -$13.1M ﹤0.01% 2570
2023
Q4
$12.3M Buy
212,300
+16,600
+8% +$886K 0.03% 577
2023
Q3
$10.3M Sell
195,700
-2,500
-1% -$131K 0.03% 517
2023
Q2
$10.7M Buy
198,200
+15,300
+8% +$799K 0.03% 483
2023
Q1
$9.15M Sell
182,900
-62,900
-26% -$2.96M 0.03% 518
2022
Q4
$11.4M Buy
245,800
+14,200
+6% +$615K 0.03% 667
2022
Q3
$8.97M Sell
231,600
-92,600
-29% -$3.71M 0.02% 797
2022
Q2
$12.1M Buy
324,200
+48,000
+17% +$1.95M 0.02% 725
2022
Q1
$12.2M Sell
276,200
-594,700
-68% -$25.8M 0.01% 868
2021
Q4
$37M Buy
870,900
+158,700
+22% +$6.67M 0.03% 396
2021
Q3
$30.9M Buy
712,200
+422,500
+146% +$18.7M 0.03% 423
2021
Q2
$12.4M Buy
289,700
+14,900
+5% +$627K 0.01% 928
2021
Q1
$10.6M Sell
274,800
-463,600
-63% -$17.5M 0.02% 889
2020
Q4
$26.5M Buy
738,400
+165,800
+29% +$5.98M 0.05% 345
2020
Q3
$21.9M Sell
572,600
-20,500
-3% -$790K 0.07% 248
2020
Q2
$20.8M Buy
593,100
+249,300
+73% +$8.98M 0.1% 218
2020
Q1
$11.2M Buy
343,800
+222,200
+183% +$8.68M 0.09% 224
2019
Q4
$5.5M Buy
121,600
+14,600
+14% +$611K 0.04% 624
2019
Q3
$4.35M Buy
107,000
+31,000
+41% +$1.31M 0.04% 668
2019
Q2
$3.27M Buy
76,000
+60,000
+375% +$2.31M 0.03% 767
2019
Q1
$614K Buy
16,000
+10,700
+202% +$409K 0.01% 1785
2018
Q4
$187K Sell
5,300
-12,000
-69% -$435K ﹤0.01% 2735
2018
Q3
$666K Sell
17,300
-22,200
-56% -$775K 0.01% 2028
2018
Q2
$1.29M Buy
39,500
+37,100
+1,546% +$1.12M 0.01% 1471
2018
Q1
$66K Sell
2,400
-2,600
-52% -$70.7K ﹤0.01% 3508
2017
Q4
$124K Buy
5,000
+3,100
+163% +$85.5K ﹤0.01% 3231
2017
Q3
$55K Buy
1,900
+1,300
+217% +$35.9K ﹤0.01% 3579
2017
Q2
$17K Sell
600
-100,000
-99% -$2.65M ﹤0.01% 4007
2017
Q1
$2.5M Sell
100,600
-219,700
-69% -$5.34M 0.03% 729
2016
Q4
$6.93M Buy
320,300
+82,200
+35% +$1.79M 0.07% 319
2016
Q3
$5.67M Buy
238,100
+149,700
+169% +$3.57M 0.06% 364
2016
Q2
$2.07M Buy
88,400
+25,100
+40% +$543K 0.02% 812
2016
Q1
$1.19M Buy
63,300
+9,200
+17% +$162K 0.02% 1060
2015
Q4
$998K Sell
54,100
-10,300
-16% -$185K 0.01% 1325
2015
Q3
$1.06M Sell
64,400
-18,900
-23% -$323K 0.01% 1198
2015
Q2
$1.47M Sell
83,300
-17,100
-17% -$306K 0.02% 940
2015
Q1
$1.78M Buy
100,400
+11,200
+13% +$177K 0.03% 706
2014
Q4
$1.18M Sell
89,200
-25,000
-22% -$320K 0.02% 977
2014
Q3
$1.35M Buy
114,200
+104,800
+1,115% +$1.32M 0.02% 916
2014
Q2
$120K Sell
9,400
-32,400
-78% -$421K ﹤0.01% 2812
2014
Q1
$565K Buy
41,800
+200
+0.5% +$2.63K 0.01% 1553
2013
Q4
$500K Buy
41,600
+9,000
+28% +$106K 0.01% 1658
2013
Q3
$383K Buy
32,600
+28,100
+624% +$304K 0.01% 1841
2013
Q2
$42K Buy
+4,500
New +$38.2K ﹤0.01% 3556

Other funds holding BSX

Group One Trading's BSX Position: Q1 2026 in Review

Group One Trading increased its Boston Scientific (BSX) stake by 201% in Q1 2026, buying an estimated $3.55M and bringing the position to 66,446 shares worth $4.17M. The position accounts for 0.01% of the portfolio, ranked #1447.

Group One Trading first reported a position in BSX in Q2 2013 and has held it in 39 quarters since. The position peaked at $15M in Q4 2020. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Group One Trading held 66,446 shares of Boston Scientific worth $4.17M as of Q1 2026.
  • Group One Trading bought 44,402 Boston Scientific shares in Q1 2026, an estimated $3.55M.
  • Boston Scientific made up 0.01% of Group One Trading's portfolio in Q1 2026, its #1447 holding.
  • Group One Trading first reported a position in Boston Scientific in Q2 2013 and has held it in 39 quarters since.
  • Group One Trading's Boston Scientific position peaked at $15M in Q4 2020.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.